Startups
IntraBio

New drug application (NDA) IB1001 developer for the treatment of Niemann-pick disease type C (NPC).

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 67

Locations

Company Size

  • 1 - 11

Last Stage Round

Industry

Total Funding
$50.6M
Full Company Profile